article thumbnail

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Drug Discovery Today

Exploratory research project aims to develop novel protein expression systems via cell reprogramming

article thumbnail

Researchers identify potential therapeutic target for early-onset dementia

Drug Discovery World

The research led by scientists from the Medical Research Council (MRC) Laboratory of Molecular Biology, in Cambridge, UK, could provide a target for the future development of diagnostic tests and treatments. Surprisingly, the protein was not FUS – it was another protein called TAF15.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

smartRNA project joins BII Bio Studio programme

Drug Discovery World

The project will be led by Søren Lykke-Andersen, a Senior Scientist at Aarhus University (AU), working at the Department of Molecular Biology and Genetics.

RNA 130
article thumbnail

Tech Theatre ELRIG 2022: First steps towards liquid handling automation

Drug Discovery World

Product Manager at SPT Labtech, for a fascinating deep dive into the practical considerations of how, when and why you should automate your laboratory’s liquid handling processes. in Chemical Biology. Join Anne Hammerstein, Ph.D., The talk will take place at ELRIG’s Drug Discovery 2022 Tech Theatre, supported by DDW.

article thumbnail

Open-source lab robot makes bioautomation accessible for all

Drug Discovery World

Opentrons says that while legacy laboratory robotics require extensive software knowledge and months of training, the Flex has an open-source design and accessible application programming interface (API), especially useful for scientists advancing generative AI.

article thumbnail

Merkin Prize in Biomedical Technology awarded to F. William Studier for development of widely used protein- and RNA-production platform

Broad Institute

William Studier for development of widely used protein- and RNA-production platform The $400,000 award recognizes the far-reaching medical impacts of Studier’s development, in the 1980s, of an efficient and scalable technology to produce mass amounts of RNA and proteins in laboratories that is widely used today all over the world.

RNA 84
article thumbnail

AI provides new insight into preventing human disease

Drug Discovery World

The study was conducted by researchers at the Universities of Bristol (UK) and Queensland (Australia), and the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK.

Disease 130